APLICATIONS

Diffusion Pharmaceuticals Inc. (Nasdaq: DFFN) Declares $12M Underwritten Public Offering

Diffusion prescription drugs INC. (Nasdaq: DFFN), a clinical-stage biotechnology company taking note to extending the anticipation of cancer patients, recently declared that it had...

HOT NEWS